Search results
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...
This conversation between Daphne Koller and Joel Hellermark was recorded in April 2024 at the insitro’s headquarters in San Francisco. An edited version was ...
Oct 25, 2023 · Koller is an adjunct professor of computer science at Stanford. Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI ...
Shared by Daphne Koller. For most of my career, I've been working at the boundary of two disciplines: machine…. · Experience: insitro · Education: UC Berkeley Electrical Engineering & Computer ...
- 500+
- Insitro
- 15K
- San Francisco Bay Area
Apr 20, 2022 · Daphne Koller. With healthy ($500 million plus) financing and major deals with pharma and Genomics England, insitro is one of the standouts of AI in drug discovery and development. Koller’s goal ...